The latest issue of the Department of Health’s weekly vaccine update can be found here and includes a link for members to sign up to receive it directly.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

MDH (Minnesota Department of Health) has updated the Interim COVID-19 Vaccine Provider Guide, Template: COVID-19 Screening and Agreement and created the Pfizer-BioNTech COVID-19 Vaccine Protocol for 6 months through 4 years and Moderna COVID-19 Vaccine Protocol for 6 months through 5 years. Find these resources at COVID-19 Vaccine Providers.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

HF 4065, an omnibus health care bill was signed into law by Gov. Tim Walz (D). The bill includes a provision that allows pharmacists to administer intramuscular and subcutaneous drug injections and to place drug monitoring devices according to prescription, protocols, or collaborative practice agreements.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

To view this week’s Department of Health COVID-19 vaccine provider weekly update, past updates or to subscribe to them click here.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Several bills have been introduced to advance NACDS' Scope of Business Campaign. HF 4008 and SF 3823 would provide payment parity for pharmacy-based services and HF 4009 would update the states' pharmacy immunization and testing authority to match the PREP Act.  

Also in Minnesota, the House Health Finance and Policy Committee heard HF 3854, allowing pharmacists to prescribe HIV prevention medications. NACDS and our in-state partners were instrumental in forming a coalition of stakeholders that is proactively advancing the bill. Committee members had no major concerns and there was no opposition voiced at the hearing from the medical community. The committee held the bill over for possible inclusion in an omnibus committee bill. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Companion bills, SF 3154, and HF 3854, allowing pharmacists to initiate treatment for PeP (Post Exposure Prophylaxis) and PReP (Pre-Exposure Prophylaxis), have been introduced by Sen. Scott Dibble (DFL) and Rep. Athena Hollins (DFL). The language has been updated from last session, reflecting the work of a broad coalition of supporters formed by the joint efforts of NACDS, the Minnesota Retailers Association, the Minnesota Pharmacists Association, patient advocates and the bill sponsors. The bills have been referred to the appropriate committee for further consideration.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Department of Health has published a weekly covid vaccine providers report. To subscribe to it click here.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Division of Insurance of the Department of Commerce’s Final Rule on PBM Licensure and Regulation was adopted with the revisions, published in the register, and became effective Jan 18. For further detail and background or to read stakeholder comments, including those filed by NACDS, go to the Department’s rulemaking page.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

The Minnesota Department of Health (MDH) will host a public, virtual meeting on Wednesday, December 29, 2021, at 2 p.m. CST to demonstrate the functionality of the registration system and provide an update on the technical build for the Prescription Drug Price Transparency Act (the "Act") (Minnesota Statutes 62J.84; amended by Minnesota Laws, 2021, Regular Session, Chapter 30 – HF 2128 – Article 3, Sec. 5 – 9). To join, use the  Webex Meeting Link, Meeting Number (access code): 2494 346 4226, Meeting Password: tXaTGFdT722. MDH will post–meeting materials on the Prescription Drug Price Transparency Meetings page. Additional information is available online at www.health.state.mn.us/data/rxtransparency, where interested individuals and stakeholders may also subscribe to periodic updates. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.